Larvol Delta - P53MVA-and-Pembrolizumab-in-Treating-Patients-With-Recurrent-Ovarian-Primary-Peritoneal-or-Fallopian-Tube-Cancer

p53MVA - Tara I-O

Keytruda (pembrolizumab) - Merck (MSD)

http://clinicaltrials.gov/ct2/show/NCT03113487

Jul 17, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next